Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Liver Cirrhosis: full-pipeline trial registry
6 of 16 indexed Liver Cirrhosis trials are currently recruiting.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 6 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Liver Cirrhosis: 16 US clinical trials tracked, 6 recruiting.
Liver Cirrhosis is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Sanofi, running 2 of these trials.
Enrollment posture brief
Registry condition liver-cirrhosis
OPEN 6 | RECR 38% | LATE 4 | EARLY 3 | RANK #1060 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)
Liver Cirrhosis lists 6 open slots (38% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Liver Cirrhosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Liver Cirrhosis is recruiting below its size-band peers.
6 of 16 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Liver Cirrhosis trials is spread across many organizations.
Sanofi accounts for 2 of 16 trials (12.5%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical Liver Cirrhosis enrolment sits around 213 participants.
Median target enrolment is 213 among the 16 trials that report a genuine target (sentinel values excluded). 7 of those (43.8%) plan for fewer than 100 participants.
-
Liver Cirrhosis splits between interventional and observational designs.
10 interventional and 6 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
National Liver Cancer Screening Trial
University of Texas Southwestern Medical Center
NCT06084234
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
European Foundation for Study of Chronic Liver Failure
NCT04613921
Multi-analyte Blood Test Clinical Trial
Helio Genomics
NCT05199259
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Massachusetts General Hospital
NCT06265272
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Massachusetts General Hospital
NCT05205954
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Boehringer Ingelheim
NCT07325526
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
University of Washington
NCT04281784
International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project
Azienda Ospedaliera di Padova
NCT05387811
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
Sanofi
NCT00358878
Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed
University of Texas Southwestern Medical Center
NCT00689754
Prevention of Esophageal Varices by Beta-Adrenergic Blockers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00006398
Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
Sanofi
NCT00501722
A Study of IDN-6556 in Subjects With Liver Cirrhosis
Conatus Pharmaceuticals
NCT02230670
Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements
Cook Research Incorporated
NCT04668664
Steroid Free Immunosuppression in Liver Transplantation
Thomas Jefferson University
NCT00296244
Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI
Stanford University
NCT03342703
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Liver Cirrhosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Liver Cirrhosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Liver Cirrhosis page
16 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Liver Cirrhosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sanofi sponsors the most Liver Cirrhosis trials on record, review their full trial history before evaluating a specific study. See Sanofi's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Liver Cirrhosis condition card totals 16 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.